Back to search

Agricultural University of Athens

Εφαρμογή υπολογιστικών μεθόδων στην στόχευση πρωτεϊνών για την καταστολή διεργασιών αναγνώρισης και μεταβολισμού φυσιολογικού και καρκινικού κυττάρου

Abstract

dc:description

Cancer characterizes a group of diseases where uncontrolled cell proliferation is denoted as a common feature. Unlike normal cells, which grow, divide, and die in a tightly controlled manner, cancer cells alter normal processes of the cell cycle. Many answers to the treatment of diseases can be given by targeted protein inhibition in important cellular pathways, since proteins constitute the most versatile macromolecules involved in all biological pathways in cells. A principal question in basic cancer research and cancer therapy lies in decoding the differences between normal and cancer cells for the effective design and development of drugs with selective action. One of the most fundamental changes between cancer and normal cells is the alteration of the metabolic pathway. In normal cells, metabolism includes aerobic glycolysis, and oxidative phosphorylation, through which energy gain is attributed to the cell with the production of adenosine triphosphate (ATP). In contrast, cancer cells are characterized by increased aerobic glycolysis and use predominantly this metabolic pathway to produce ATP as the main source of energy, a phenomenon also known as the Warburg effect. Consequently, cancer cells exhibit reduced oxidative phosphorylation and increased production of building blocks required for cell growth and proliferation. The strategic study of the glycolytic pathway of cancer cell metabolism involves the study of important protein molecules, whilst the contribution of protein homeostasis may elucidate the molecular mechanisms underlying carcinogenesis. In recent years, a lot of emphasis has been given to monocarboxylate transporter 4 (MCT4), a protein widely distributed in glycolytic tissues. Many studies confirm the role of MCT4 as a transporter of L-lactate in cancer cells with a glycolytic phenotype, and the inhibition of MCT4 is predicted to induce of lactic acidosis, disruption of glycolysis, and death of the cancer cell. To date and to the best of our knowledge, while literature and experimental studies show that MCT4 inhibition has an anticancer effect, there is no known inhibitor that acts selectively against MCT4 and blocks the efflux of lactate from the cancer cell. Aiming towards the structural characterization of MCT4 for anticancer drug design, in this thesis we employed a rational pipeline for anticancer therapeutic strategies, comprised of molecular modeling approaches, molecular dynamics simulations, and the creation of a three-dimensional pharmacophoric model as a novel approach for the discovery of specific MCT4-inhibitors.MCT4 is a transmembrane transporter composed of 12 transmembrane helices with a distinguished symmetry between the N-terminal and C-terminal domains, TM1-6 and TM7-12 respectively, linked through a flexible cytoplasmic loop. This characteristic structure forms a core transport channel and assigned flexibility to the transporter, supporting the 'rocker switch' mechanism. Through this mechanism, the transporter acquires different conformations (inward open and outward open conformation) alternating the substrate access through the membrane. To date, there is no crystal structure for MCT4, and due to the limitations of membrane structures in crystallography there is limited availability of homologous transporters. In order to create a representative MCT4 model, a holistic phylogenetic analysis was firstly performed to investigate the evolutionary relationship of MCT4 amongst species, as well as the evolutionary relationship amongst the SLC16 family members in mammals. The SLC16 phylogeny shows a close evolutionary relationship between MCT1-4, while the remaining members show a distant relationship, with MCT8 and MCT10 responsible for the transport of thyroid hormones and aromatic amino acids, respectively, having the most distant evolutionary relationship. Among species, MCT4 is localized in the animal and fungal kingdoms, and the N-terminal structural region of the protein (TM1-TM6) shows a higher level of conservation as it is mainly involved in proton binding and monocarboxylate transporter insertion into the membrane, while the C- terminal structural region (TM7-TM12) involved in substrate binding shows a lower percentage of conserved amino acid residues. The phylogenetic analysis led to a hybrid approach of template selection and threading was employed to model the three-dimensional structure of human MCT4 (hMCT4), based on the conserved structure of the Major Facilitator Superfamily (MFS) transporters, and selecting by structural groups of sequence similarity the appropriate templates. The final 3-D homology model was based on the crystal structure of the glucose transporter hGLUT1, which facilitates glucose translocation across the membrane with a prominent role in cancer metabolism, and the crystal structure of a bacterial MCT4 homologue, Syntrophobacter fumaroxidans MPOB (SfMOB), that exhibits the highest homology amongst the identified crystal structures. The resulting 3D model was energetically minimized and evaluated for its overall structural and energetic features and its orientation in the membrane. The model was found to retain all features known for MCT4 conformation, such as the orientation and position of transmembrane helices in the membrane and the accessibility and orientation of ‘key’ aminoacids that participate in the transport mechanism as well as the overall structural stability of MCT4. The model was then subjected to molecular dynamics protocols to simulate the transporter in the membrane and was found to maintain an overall stable energetic state between alternating conformations. A pharmacophore model was then designed as a dynamic approach based on protein structure and molecular dynamics simulations. Following an initial 'blind' search for pharmacophoric elements against the protein structure, and through a mathematical spatiotemporal analysis of physicochemical characteristics attributed to the conformations predicted by molecular dynamics simulations, the most important pharmacophore properties consistent over the course of the simulation time were chosen. The designed 3D pharmacophore model consisted of seven important features in the transport channel core, one projected aromatic ring group, five projected hydrogen bond acceptor sites, and one group representing both hydrogen bond acceptor and donor. These features are associated with important hMCT4 amino acid residues involved in substrate translocation as well as alternative conformations acquired by the transporter. Finally, to evaluate the pharmacophore model and assess its potential for predicting novel specific substrates for MCT4 inhibition, a computational comparison was performed against experimentally determined compounds with inhibitory propensity, verifying the analogies of the pharmacophoric properties of the present model with the experimental data. The holistic approach and methodology that was employed herein resulted in the design of a representative MCT4 homology model and a consequent pharmacophore model available for systematic screening for potential MCT4 inhibitors, and constitutes an innovative pathway in rational drug design and in our effort to develop novel anticancer strategies.

Degree

thesis:*
Grantor dc:publisher
Agricultural University of Athens
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papakonstantinou, Eleni
  • Παπακωνσταντίνου, Ελένη

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55485

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papakonstantinou, Eleni; Παπακωνσταντίνου, Ελένη. Εφαρμογή υπολογιστικών μεθόδων στην στόχευση πρωτεϊνών για την καταστολή διεργασιών αναγνώρισης και μεταβολισμού φυσιολογικού και καρκινικού κυττάρου. Agricultural University of Athens, 2023. http://hdl.handle.net/10442/hedi/55485